142TiPA prospective multi-center study to investigate the EGFR-TKI resistance profile, treatment algorithm and clinical outcome in Chinese patients with advanced EGFRm+ NSCLC who have received prior first generation EGFR TKI (PRECENT study, CCTC-1601, NCT02988141)

    Annals of Oncology, 2017.

    Cited by: 0|Bibtex|Views2|

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments